Speaker Pelosi praises Obama's announcement to help veterans with PTSD get easier access to treatment

NewsGuard 100/100 Score

Speaker Nancy Pelosi released the following statement today praising President Obama's announcement that the Department of Veterans Affairs will start making it easier for veterans with Post Traumatic Stress Disorder to receive critical health and disability benefits and treatment:

"In every generation, America sends our sons and daughters to distant shores to fight on behalf of our freedom, our values, and our safety and security. Their sacrifice is a source of pride for our nation; their service is a source of inspiration to us all. We owe our deepest debt of gratitude to those who give their lives for our country; and we must do everything in our power to care for those who return safely home.

"Today's new regulations by the Department of Veterans Affairs will help veterans with PTSD get easier access to the treatment and benefits they need and have earned. This long overdue change marks a critical step forward for the health and well-being of those who have served in Iraq, Afghanistan, and all of our nation's wars.

"This Congress and this Administration have made a solemn pledge to the members of our military: that just as they refuse to leave anyone behind on the battlefield, we will not leave any veteran behind when they come home. In making this change today, we are keeping our promise."

Visit Speaker.gov

Source:

Office of the Speaker of the House

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Phase 2 trial reveals Lixisenatide may reduce motor disability in Parkinson’s patients